Hydroxyethyl Starch + Sodium Chloride
Each 100 ml contains:
Poly (O-2-hydroxyethyl) starch 6.0 gmSodium Chloride 0.9 g (Equals 154 mmol/L Na+ and 154 mmol/L Cl-)Water for Injections q.s to 100 mlOsmolarity (Theoretical) 308 mOsm/L, pH 3.5-6.0.Colloidal solution volume expander that contains hydroxyethyl starch.
Poly(O-2-hydroxyethyl)starch6.0gmSodiumChloride0.9g(Equals154mmol/LNa+and154mmol/LCl-)WaterforInjectionsq.sto100mlOsmolarity(Theoretical)308mOsm/L,pH3.5-6.0.Colloidalsolutionvolumeexpanderthatcontainshydroxyethylstarch.
ব্যবহার
Therapy and prophylaxis of volume deficiency (hypovolaemia) and shock (volume replacement therapy) in connection with surgery (haemorrhagic shock). Injuries (traumatic shock), infections (septic shock), bums (bum shock). Savings of donor blood during surgery e,g acute normovolaemic haemodilution. Therapeutic dilution of blood (haemodilution)
Hydroxyethyl Starch + Sodium Chloride এর দাম কত? Hydroxyethyl Starch + Sodium Chloride এর দাম
সুচিপত্র
| বাণিজ্যিক নাম | Hydroxyethyl Starch + Sodium Chloride |
| জেনেরিক | Hydroxyethyl Starch + Sodium Chloride |
| ধরণ | |
| পরিমাপ | |
| দাম | |
| চিকিৎসাগত শ্রেণি | Plasma expanders |
| উৎপাদনকারী | |
| উপলভ্য দেশ | Bangladesh |
| সর্বশেষ সম্পাদনা | September 24, 2024 at 5:38 am |
খাওয়ার নিয়ম / ব্যবহারের নিয়ম
Hydroxyethyl Starch + Sodium Chloride খাওয়ার নিয়ম / ব্যবহারের নিয়ম
Adult: Dose Up to 50 mL of (hydroxyethyl starch in sodium chloride injection) per kg of body weight per day (equivalent to 3 g hydroxyethyl starch and 7.7 mEq sodium per kg of body weight). This dose is equivalent to 3500 mL of (hydroxyethyl starch in sodium chloride injection) for a 70 kg patient.
Pediatric Dose: Dosage in children should be adapted to the individual patient colloid needs, taking into account the disease state, as well as the hemodynamic and hydration status
Newborns and infants: 2-12 years: Mean dose of 36 mL/kg IV
Give initial 10-20 mL by slow IV infusion and monitor for anaphylactoid reaction
পার্শ্বপ্রতিক্রিয়া
From the accumulated clinical development experience, expected adverse reactions after administration of (hydroxyethyl starch in sodium chloride injection) occurring in less than 10% of patients are as follows: Immune system disorders (Rare, > 0.01% to < 0.1 %): anaphylactoid reactions (hypersensitivity, mild influenzalike symptoms, bradycardia, tachycardia, bronchospasm, non-cardiac pulmonary edema). In the event of an intolerance reaction, the infusion should be discontinued immediately and the appropriate emergency medical treatment initiated. Skin and subcutaneous tissue disorders (Common, > 1 to < 10%, dose dependent): Prolonged administration of high dosages of hydroxyethyl starch may cause pruritus (itching) which is an undesirable effect observed with all hydroxyethyl starches.
সতর্কতা
Anaphylactoid reactions (mild influenza-like symptoms, bradycardia, tachycardia, bronchospasm, non-cardiac pulmonary edema) have been reported with solutions containing hydroxyethyl starch. If a hypersensitivity reaction occurs, administration of the drug should be discontinued immediately and the appropriate treatment and supportive measures should be undertaken until symptoms have resolved. Fluid status and rate of infusion should be assessed regularly during treatment, especially in patients with cardiac insufficiency or severe kidney dysfunction. In cases of severe dehydration, a crystalloid solution should be given first. Generally, sufficient fluid should be administered in order to avoid dehydration. Caution should be observed before administering (hydroxyethyl starch in sodium chloride injection) to patients with severe liver disease or severe bleeding disorders (e.g., severe cases of von Willebrand's disease).
মিথস্ক্রিয়া
The safety and compatibility of other additives, other than citrate anticoagulant, have not been established. Incompatibilities: In the absence of incompatibility studies this medicinal product must not be mixed with other medicinal products.
গর্ভাবস্থাকালীন ব্যবহার
Use in pregnancy: Animal reproduction studies have not been conducted with Hydroxyethyl Starch in Sodium Chloride infusion and it is also not known whether it can cause fetal harm or affect reproductive capacity when administered during pregnancy. This infusion should be given during pregnancy only if clearly needed
Use during lactation: It is not known whether Hydroxyethyl starch is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Hydroxyethyl Starch in Sodium Chloride infusion is administered to a nursing woman.
বৈপরীত্য
Known hypersensitivity to hydroxyethyl starch fluid overload (hyperhydration) and especially in cases of pulmonary edema and congestive heart failure renal failure with oliguria or anuria not related to hypovolemia patients receiving dialysis treatment severe hypernatremia or severe hyperchloremia intracranial bleeding.
